Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma.
Sebastian NT, Tan Y, Miller ED, Williams TM, Alexandra Diaz D. Sebastian NT, et al. Among authors: tan y. Clin Transl Radiat Oncol. 2019 Jul 26;19:66-71. doi: 10.1016/j.ctro.2019.07.007. eCollection 2019 Nov. Clin Transl Radiat Oncol. 2019. PMID: 31517072 Free PMC article.
Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy.
Sebastian N, Wu T, Bazan J, Driscoll E, Willers H, Yegya-Raman N, Bond L, Dwivedi A, Mo X, Tan Y, Xu-Welliver M, Haglund K, Jabbour SK, Keane FK, Williams TM. Sebastian N, et al. Among authors: tan y. Radiother Oncol. 2019 May;134:151-157. doi: 10.1016/j.radonc.2019.01.032. Epub 2019 Feb 15. Radiother Oncol. 2019. PMID: 31005209 Free PMC article.
Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer.
Sebastian N, Wu T, Driscoll E, Willers H, Kelly S, Musunuru HB, Mo X, Tan Y, Bazan J, Haglund K, Xu-Welliver M, Baschnagel AM, Ju A, Keane F, Williams TM. Sebastian N, et al. Among authors: tan y. Radiother Oncol. 2019 Nov;140:26-33. doi: 10.1016/j.radonc.2019.05.014. Epub 2019 Jun 5. Radiother Oncol. 2019. PMID: 31176206 Free PMC article.
A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
Sebastian NT, Miller ED, Yang X, Diaz DA, Tan Y, Dowell J, Spain J, Rikabi A, Elliott E, Knopp M, Williams TM. Sebastian NT, et al. Among authors: tan y. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1276-1283. doi: 10.1016/j.ijrobp.2020.07.033. Epub 2020 Jul 23. Int J Radiat Oncol Biol Phys. 2020. PMID: 32712254 Clinical Trial.
Phase I study of trametinib in combination with whole brain radiation therapy for brain metastases.
Palmer JD, Prasad RN, Fabian D, Wei L, Yildiz VO, Tan Y, Grecula J, Welliver M, Williams T, Elder JB, Raval R, Blakaj D, Haglund K, Bazan J, Kendra K, Arnett A, Beyer S, Liebner D, Giglio P, Puduvalli V, Chakravarti A, Wuthrick E. Palmer JD, et al. Among authors: tan y. Radiother Oncol. 2022 May;170:21-26. doi: 10.1016/j.radonc.2022.03.016. Epub 2022 Mar 31. Radiother Oncol. 2022. PMID: 35367525 Clinical Trial.
14,981 results
You have reached the last available page of results. Please see the User Guide for more information.